India unveils equipment to mark, fence minefields quicker & semi-automatically
SECTIONS
Last Updated: May 19, 2021, 04:42 PM IST
Share
Synopsis
An Atmanirbharta product, the Mechanical Minefield Marking Equipment MK II, was built on BEML TATRA 6x6 (a high mobility vehicle) and developed through transfer of technology from Pune-based Research and Development Establishment (Engineers), a lab of Defence Research and Development Organisation (DRDO).
The first prototype of a mechanical equipment designed for marking and fencing mine fields at a faster rate and semi-automatically with minimal human intervention was rolled out by
An Atmanirbharta product, the Mechanical Minefield Marking Equipment MK II, was built on BEML TATRA 6x6 (a high mobility vehicle) and developed through transfer of technology from Pune-based Research and Development Establishment (Engineers), a lab of Defence Research and Development Organisation (DRDO).
NEW DELHI: Dr Reddy s on Wednesday said that the supply of anti-Covid drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO) is expected to commence in mid-June.
In a statement, Hyderabad based Dr Reddy s said that the drug has not been launched in the market yet and people should be cautious of agents selling spurious or illegal products in the name of 2DG.
The anti-Covid therapeutic application of the drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with Dr Reddy s Laboratories (DRL) in Hyderabad.
COVID: Army finds solution for conversion of liquid oxygen to low pressure oxygen gas
SECTIONS
Last Updated: May 19, 2021, 08:59 PM IST
Share
Synopsis Since oxygen was transported in liquid form in cryogenic tanks, quick conversion of liquid oxygen to oxygen gas and ensuring availability at the patients bed was a critical challenge faced by all hospitals managing COVID patients, the statement said.
PTI
The Indian Army said on Wednesday it has found a solution for efficient conversion of liquid oxygen to low pressure oxygen gas that can be given to COVID-19 patients at their hospital beds. Over seven days, the team of Army engineers in-direct consultation and material support from CSIR & DRDO put together a working solution using vaporisers, pressure relief valves and liquid oxygen cylinders, the Army s statement noted.
India News: Dr Reddy's on Wednesday said that the supply of anti-Covid drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisati
Synopsis
The Drugs Controller General of India (DGCI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients earlier this month.
Rajnath Singh, Harsh Vardhan release DRDO s 1st batch of anti-Covid drug 2DG
The first batch of anti-COVID oral drug 2-DG, developed by the DRDO, was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan.
The Drugs Controller General of India (DGCI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients earlier this month.
In his brief remarks, Singh said the drug has brought a new ray of hope for the treatment of COVID-19 patients.